NEW ORLEANS—A new oral tyrosine kinase inhibitor drug — idelalisib — has proved effective — and to have low toxicity — in patients with chronic lymphocytic leukaemia (CLL). Richard Furman MD from Weill Cornell Medical College in New York announced...
The rare, fatal lympho-proliferative condition: Multicentric Castleman’s Disease — MCD — could soon be treatable following findings announced at the American Society of Hematology annual meeting in New Orleans. Dr. Raymond S Wong MD, PhD — who is a...
LONDON— Researchers have shown that endometrial cancer — and hopefully ovarian cancer too — could potentially be detected much earlier than at present — or even prevented altogether — by looking for ‘silencing’ by DNA methylation of the HAND2 gene:...
NEW ORLEANS—High remission rates with extended survival are being achieved in patients who had failed all other therapies — including allogeneic stem cell transplantation — for their acute lymphoblastic leukemia and otherwise had very short life...
AMSTERDAM— New hopes for smokers with lung cancer were raised at the 2013 European Cancer Congress here by research findings from France, Spain and the USA using a new form of immunotherapy to treat refractory disease. Professor Jean-Charles Soria...
AMSTERDAM— Organized screening for prostate cancer using the prostate-specific antigen (PSA) test does more harm than good, according to the findings of a French study reported here at the 2013 European Cancer Congress. With more than half of all...
AMSTERDAM—Women with HER-2 positive metastatic breast cancer had significantly improved time to progression with fewer side effects after treatment with the antibody-drug conjugate T-DM1 compared to conventional therapies in the phase three TH3RESA...
AMSTERDAM—Women with HER-2 positive metastatic breast cancer had significantly improved time to progression with fewer side effects after treatment with the antibody-drug conjugate T-DM1 compared to conventional therapies in the phase three TH3RESA...
LONDON— Intraoperative radiotherapy given at the time of lumpectomy was found to be ‘non-inferior’ to the use of conventional post-operative whole breast external beam radiotherapy and had equivalent breast cancer specific mortality but fewer non...
AMSTERDAM—Screening men and women for colorectal cancer (CRC) with either fecal occult blood testing (FOBT) or endoscopy markedly lowered disease incidence and mortality in a study of screening patterns in 11 European countries over the last 20...
AMSTERDAM—Locoregional radiotherapy to the internal mammary and medial supraclavicular lymph nodes in women who had already been treated successfully for their breast cancer with standard regimens — including surgery, radiotherapy and, when needed...
AMSTERDAM—Long term survival — three to ten years — in nearly a quarter of patients with unresectable, metastatic or locally advanced melanoma treated with the cytotoxic T-lymphocyte antigen 4 (CTLA-4)-inhibiting monoclonal antibody ipilimumab was...